Back to search

Article

CDK7 is a Novel Therapeutic Vulnerability in Fibrolamellar Carcinoma

2023-04-23

Abstract excerpt

<h4>Summary</h4> Fibrolamellar carcinoma (FLC) is a rare and lethal cancer that afflicts young individuals. The tumor arises in the background of a healthy liver, and patients typically present with advanced cancer at the time of diagnosis. Unfortunately, for these patients with advanced or recurrent cancer, no proven systemic therapies exist resulting in only 30-45% of patients surviving to 5 years. Investigatio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
880ede6b-f31e-5c7e-91ec-61c085d7769f
DOI
10.1101/2023.04.22.537934
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CDK7 is a Novel Therapeutic Vulnerability in Fibrolamellar CarcinomaDOI 10.1101/2023.04.22.537934
Select a neighboring publication to make it the new centre.